Gennate

Gennate, a developer of next-generation plant nutrition nanomaterials, has successfully completed a £550,000 seed funding round. The investment was led by SFC Capital, with additional participation from the GM Advance Fund and the Salonica Infinity Fund.

Summary of transaction details:

• Value: £550,000
• Sector: Healthcare & Biotech
• Advisor: N/A
• Key Entities: Gennate (Target), SFC Capital, GM Advance Fund, Salonica Infinity Fund (Investors)
• Location: Stockport, UK (with laboratory space at Manchester Science Park)

Note: This funding is intended to support the creation of up to 15 new jobs and underpin the continued development and expansion of Gennate's innovative nanomaterials technology.